Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Integra Lifesciences Holdings (IART) Payables (2016 - 2026)

Integra Lifesciences Holdings' Payables history spans 17 years, with the latest figure at $95.7 million for Q4 2025.

  • On a quarterly basis, Payables rose 16.03% to $95.7 million in Q4 2025 year-over-year; TTM through Dec 2025 was $95.7 million, a 16.03% increase, with the full-year FY2025 number at $95.7 million, up 16.03% from a year prior.
  • Payables hit $95.7 million in Q4 2025 for Integra Lifesciences Holdings, up from $92.3 million in the prior quarter.
  • Over the last five years, Payables for IART hit a ceiling of $112.8 million in Q1 2023 and a floor of $59.6 million in Q3 2021.
  • Historically, Payables has averaged $86.1 million across 5 years, with a median of $91.8 million in 2025.
  • Biggest five-year swings in Payables: crashed 36.64% in 2021 and later soared 65.11% in 2022.
  • Tracing IART's Payables over 5 years: stood at $61.8 million in 2021, then soared by 65.11% to $102.1 million in 2022, then dropped by 9.57% to $92.3 million in 2023, then decreased by 10.64% to $82.5 million in 2024, then rose by 16.03% to $95.7 million in 2025.
  • Business Quant data shows Payables for IART at $95.7 million in Q4 2025, $92.3 million in Q3 2025, and $92.8 million in Q2 2025.